SFM
IMNM icon

Sphera Funds Management’s Immunome IMNM Stock Holding History

Sphera Funds Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-147,200
Closed -$1.72M – 115
2025
Q3 		$1.72M Buy
+147,200
New +$1.46M 0.36% 79

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Sphera Funds Management's IMNM Position: Q4 2025 in Review

Sphera Funds Management sold out of Immunome (IMNM) in Q4 2025, closing a stake of 147,200 shares — an estimated $1.72M sold.

Sphera Funds Management first reported a position in IMNM in Q3 2025 and held it in 1 quarter. The position peaked at $1.72M in Q3 2025. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Sphera Funds Management reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • Sphera Funds Management sold 147,200 Immunome shares in Q4 2025, an estimated $1.72M.
  • Sphera Funds Management first reported a position in Immunome in Q3 2025 and held it in 1 quarter.
  • Sphera Funds Management's Immunome position peaked at $1.72M in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Sphera Funds Management's 13F filing for Q4 2025, filed 17 Feb 2026.